1. Home
  2. GDTC vs LRE Comparison

GDTC vs LRE Comparison

Compare GDTC & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • LRE
  • Stock Information
  • Founded
  • GDTC 2018
  • LRE 2001
  • Country
  • GDTC Singapore
  • LRE Japan
  • Employees
  • GDTC N/A
  • LRE N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • LRE
  • Sector
  • GDTC Health Care
  • LRE
  • Exchange
  • GDTC Nasdaq
  • LRE Nasdaq
  • Market Cap
  • GDTC 21.5M
  • LRE 24.0M
  • IPO Year
  • GDTC 2023
  • LRE 2023
  • Fundamental
  • Price
  • GDTC $1.77
  • LRE $1.53
  • Analyst Decision
  • GDTC Buy
  • LRE
  • Analyst Count
  • GDTC 1
  • LRE 0
  • Target Price
  • GDTC $5.00
  • LRE N/A
  • AVG Volume (30 Days)
  • GDTC 17.4K
  • LRE 66.0K
  • Earning Date
  • GDTC 01-01-0001
  • LRE 01-01-0001
  • Dividend Yield
  • GDTC N/A
  • LRE N/A
  • EPS Growth
  • GDTC N/A
  • LRE N/A
  • EPS
  • GDTC N/A
  • LRE N/A
  • Revenue
  • GDTC $368,838.00
  • LRE $110,330,328.00
  • Revenue This Year
  • GDTC $5.37
  • LRE N/A
  • Revenue Next Year
  • GDTC N/A
  • LRE N/A
  • P/E Ratio
  • GDTC N/A
  • LRE N/A
  • Revenue Growth
  • GDTC N/A
  • LRE 3.92
  • 52 Week Low
  • GDTC $1.20
  • LRE $1.10
  • 52 Week High
  • GDTC $4.05
  • LRE $2.49
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 34.10
  • LRE 42.80
  • Support Level
  • GDTC $1.79
  • LRE $1.41
  • Resistance Level
  • GDTC $1.88
  • LRE $2.10
  • Average True Range (ATR)
  • GDTC 0.06
  • LRE 0.17
  • MACD
  • GDTC -0.00
  • LRE -0.04
  • Stochastic Oscillator
  • GDTC 4.88
  • LRE 23.46

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: